Last week marked a very exciting moment for anyone with any involvement in breast cancer patient care, including, and especially, for breast cancer patients. On February 22 2013, the FDA approved Kadcyla, a new treatment for HER-2 positive metastatic breast cancer. Kadcyla was formerly known to many in the cancer world as T-DM1 and has … Continue reading New hope in HER-2 Positive Metastatic Breast Cancer
2013 needs to be a year of major, actionable change in pharma. I am also writing about creativity squashers in Big Pharma in my mini-series "Are you there, Pharma? It's me, Liz." Related articles Are you there, Pharma? It's me, Liz. Part One: Listening and Acting (pugtato.com) Are you there Pharma? It's me, Liz. Part … Continue reading Big Pharma 2013. Will we see real commitment to change?
Welcome back to the second post in my series, "Are you there Pharma? It's me, Liz." This series identifies creative thinking squashers in Pharma and suggests strategic changes that will help Big Pharma to improve its business model, in hopes of radically changing the way Pharma goes about its business. The first post discussed … Continue reading Are you there Pharma? It’s me, Liz. Part two: What’s Killing Creativity in Big Pharma Sales Forces?
As an ex-pharma veteran, I have experienced first hand, the challenges that Big Pharma faces as it struggles to figure out how to compete in a radically changing healthcare system. This mini series focuses on some changes that I would love to see in the industry, and quite frankly, changes that are necessary if Pharma … Continue reading Are you there, Pharma? It’s me, Liz. Part One: Listening and Acting